Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function

Karin M. de Winter-de Groot, Hettie M. Janssens, Rick T. van Uum, Johanna F. Dekkers, Gitte Berkers, Annelotte Vonk, Evelien Kruisselbrink, Hugo Oppelaar, Robert Vries, Hans Clevers, Roderick H.J. Houwen, Johanna C. Escher, Sjoerd G. Elias, Hugo R. de Jonge, Yolanda B. de Rijke, Harm A.W.M. Tiddens, Cornelis K. van der Ent, Jeffrey M. Beekman

Source: Eur Respir J, 52 (3) 1702529; 10.1183/13993003.02529-2017
Journal Issue: September
Disease area: Paediatric lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Karin M. de Winter-de Groot, Hettie M. Janssens, Rick T. van Uum, Johanna F. Dekkers, Gitte Berkers, Annelotte Vonk, Evelien Kruisselbrink, Hugo Oppelaar, Robert Vries, Hans Clevers, Roderick H.J. Houwen, Johanna C. Escher, Sjoerd G. Elias, Hugo R. de Jonge, Yolanda B. de Rijke, Harm A.W.M. Tiddens, Cornelis K. van der Ent, Jeffrey M. Beekman. Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function. Eur Respir J, 52 (3) 1702529; 10.1183/13993003.02529-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: